[1]郝月兰*,安玉志,蒋双玲.血清学指标、超声软指标联合NIPT用于高龄孕妇唐氏综合征筛查中的临床价值[J].中国计划生育和妇产科,2019,(2):77-80.
 HAO Yue-lan*,AN Yu-zhi,JIANG Shuang-ling.Clinical value of serological and ultrasound soft markers combined with NIPT in Down's syndrome screening in elderly pregnant women[J].Chinese Journal of Family Planning & Gynecotokology,2019,(2):77-80.
点击复制

血清学指标、超声软指标联合NIPT用于高龄孕妇唐氏综合征筛查中的临床价值
分享到:

《中国计划生育和妇产科》[ISSN:1674-4020/CN:51-1708/R]

卷:
期数:
2019年2期
页码:
77-80
栏目:
论著与临床
出版日期:
2019-02-25

文章信息/Info

Title:
Clinical value of serological and ultrasound soft markers combined with NIPT in Down's syndrome screening in elderly pregnant women
作者:
郝月兰1*安玉志2蒋双玲3
日照市妇幼保健院,1.生殖医学中心;2.检验科;3.产科
Author(s):
HAO Yue-lan1* AN Yu-zhi2 JIANG Shuang-ling3
1. Reproductive Medicine Center;2. Clinical Laboratory;3. Department of Obstetrics,The Maternal and Child Health Hospital of Rizhao City,Rizhao Shandong 276826,P.R.China
关键词:
血清学筛查超声软指标唐氏综合征无创DNA产前检测
Keywords:
serological screening ultrasound soft indexDown's syndromenoninvasive DNA prenatal testing
分类号:
R 715.5
摘要:
目的探讨血清学指标、超声软指标(ultrasound soft markers,USM)联合胎儿染色体非整倍体无创DNA 产前检测(noninvasive prenatal testing,NIPT)用于高龄孕妇唐氏综合征(Down's syndrome,DS)筛查中的临床价值。方法回顾性分析2015年5月至2017年12月日照市妇幼保健院产检的2 984例高龄孕妇的产检和随访资料,所有产妇在孕期同时接受USM筛查和孕中期血清学筛查(second trimester serum screening,STS
Abstract:
ObjectiveTo investigate the clinical value of serum markers, ultrasound soft markers(USM) and NIPT in the screening of Down's syndrome(DS) in elderly pregnant women. MethodsRetrospective analysis of prenatal care and follow-up information of 2 984 cases

参考文献/References:

[1]Herault Y, Delabar JM, Fisher EMC, et al. Rodent models in Down syndrome research: impact and future opportunities [J]. Dis Model Mech, 2017, 10 (10): 1165-1186. [2]Szabó A, Szili K, Szabó JT, et al. Nasal bone length:prenasal thickness ratio: a strong 2D ultrasound marker for Down syndrome [J]. Prenat Diagn, 2014, 34 (12): 1139-1145. [3]Kore S, Hegde A, Kanavia D, et al. Effects of period of gestation and position of fetal neck on nuchal translucency measurement [J]. J Obstet Gynaecol India, 2013, 63 (4): 244-248. [4]Metcalfe A, Hippman C, Pastuck M, et al. Beyond trisomy 21: additional chromosomal anomalies detected through routine aneuploidy screening [J]. J Clin Med, 2014, 3 (2): 388-415. [5]Wald NJ, Bestwick JP, Huttly WJ. Improvements in antenatal screening for Down's syndrome [J]. J Med Screen, 2013, 20 (1): 7-14. [6]Kellogg G, Slattery L, Hudgins L, et al. Attitudes of mothers of children with down syndrome towards noninvasive prenatal testing [J]. J Genet Couns, 2014, 23 (5): 805-813. [7]穆兰,冉素真,魏俊,等.胎儿颈项透明层测量与染色体异常的相关性研究 [J].重庆医学,2016,45(26):3638-3639. [8]朱继红,文珂.胎儿鼻骨、颈项透明层厚度与母体血清学检测联合筛查唐氏综合征 [J].中国现代医学杂志,2016,26(22):50-53. [9]付金花.彩超检测胎儿颈项透明层厚度与胎儿发育异常的应用研究 [J].中国保健营养,2016,26(25):123-124. [10]辛娟,黄丽燕,杨文方,等.孕期综合性筛查技术评估唐氏综合征风险 [J].中国妇幼健康研究,2017,28(10):1268-1271. [11]吴杰,曾海燕.妊娠中期唐氏综合征血清学筛查与妊娠结局的研究 [J].齐齐哈尔医学院学报,2015,36(12):1723-1725. [12]陈芳,朱斌.孕中期唐氏筛查高危与不良妊娠结局的分析[J].中国现代药物应用,2017,11(16):56-57. [13]姜淑芳,付玉荣,马莹,等.9 033例孕中期血清学筛查唐氏综合征模拟调整结果分析[J].解放军医学杂志,2017,42(4):342-346. [14]唐华,邹珊静,胡浩,等.孕中期唐氏筛查临界风险截断值的初步探讨 [J].中国医师杂志,2017,19(8):1223-1225. [15]涂新枝,段纯,李玉哲,等.无创胎儿DNA检测在2 949例传统唐氏筛查临界风险孕妇中的应用 [J].天津医药,2017,45(2):180-183. [16]赵楠,付雪梅,王丹,等.吉林省孕妇产前多技术联合筛查效果分析 [J].中国妇幼保健,2017,32(4):782-785.

更新日期/Last Update: 2019-02-25